Idiopathic Pulmonary Fibrosis Animation
Scientific Animation | Investor Relations & Website Assets
Created for Endeavor Biomedicines, this medical animation focuses on how their specific hedgehog inhibitor has the potential to improve lung function and reverse the fibrotic process in the lungs of individuals with Idiopathic Pulmonary Fibrosis (IPF).
Endeavor’s investigational candidate, ENV-101, is a hedgehog signaling pathway inhibitor. By binding to and inhibiting a key receptor in the hedgehog pathway, ENV-101 stops the abnormal accumulation of the myofibroblasts that cause fibrosis. This may resolve the excessive wound-healing process seen in IPF, creating the potential to reverse fibrosis and improve lung volume and function.
Designed for a diverse audience including investors, Key Opinion Leaders (KOLs), and patients, the animation showcases the efficacy of ENV-101, supported by Endeavor’s clinical results. Strategically placed on the company’s ‘Our Science’ page, the animation serves as a key educational tool, clearly communicating the benefits of this novel treatment.
Are you interested in seeing how our scientific animation can help you?
Related work
